ArticleFrontiers in oncology2026
Patient acceptance of telemedicine for breast cancer follow-up: a cross-sectional study from Eastern China.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Telemedicine offers a potential solution to the challenges of long-term follow-up for the growing population of breast cancer survivors. However, its acceptance and the factors influencing it among Chinese patients are not well understood. Methods: This cross-sectional study evaluated telemedicine acceptance and its associated factors among 812 breast cancer patients at a tertiary hospital in Eastern China (June 2026) using structured telephone interviews. Results: Overall, 72.3% of patients showed high acceptance, yet familiarity was low: only 27.7% had prior telemedicine use and 53.4% were familiar with it. Multivariate logistic regression revealed that unmarried/divorced/widowed status (OR = 0.32), unemployment (OR = 0.30), and higher risk concerns (OR = 0.44) were independently linked to lower acceptance (all P<0.05), while higher education (junior high: OR = 2.77; bachelor+: OR = 5.97), diagnosis duration >12 months (OR = 2.67), and greater perceived benefits (OR = 12.00) were associated with higher acceptance (all P<0.05). Moderation analysis showed technological barriers reduced acceptance, but their interactions with perceived benefits (P = 0.125) and risk concerns (P = 0.090) were not significant. Telephone consultation was the most preferred modality (62.4%), especially among older, less educated, and lower-income patients, whereas video consultation was favored by younger, more educated, and higher-income patients. Discussion: While acceptance of telemedicine is high among Eastern Chinese breast cancer patients, familiarity and experience remain limited. These findings may inform future approaches to telemedicine implementation, including patient education, attention to technological barriers, and flexible modality options, particularly for vulnerable subgroups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.